Clinical Study

Bio-Data-16-01 Using Novel Objective Bio-Data To Improve Quality Of Life Assessment In Patients Undergoing Cytotoxic Chemotherapy: An Interventional Pilot Study

Posted Date: Jun 11, 2019

  • Investigator: Thomas Herzog
  • Specialties: Breast Cancer, Cancer, Gynecologic Oncology, Lung Cancer, Oncology, Ovarian Cancer
  • Type of Study: Device

The goal of this study is to capture on-treatment objective quantification of physical activity/ bio-data (steps, calories, standing time) and sleep patterns and cycles in patients receiving chemotherapy front-line for breast, lung, and ovarian cancer, and to record the impact of therapy on quality of life.


To Be Eligible: Must Be A Female With Breast, Lung, Ovarian, Fallopian Tube, Or Primary Peritoneal Cancer. Ecog Performance Of 0,1, Or 2, Patients Who Will Undergo At Least 3 Cycles Of Chemotherapy.


Breast Cancer, Ovarian Cancer, Lung Cancer

For More Information:

Uc Cancer Center

  • This contact page is monitored Monday – Friday during business hours, 8 am to 5 pm EST. Do not rely on communication through this website for medical treatment or care. This website is not designed for such purposes.
    For questions regarding clinical studies at UC Health, contact us at or (513) 245-3417.